Drug Trial Radar · NCT06401044
A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease
Last checked: Nov 20, 2026Latest source record: Aug 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
94
Actual
Start
May 30, 2024
Primary completion
Jan 6, 2027
Study completion Dec 24, 2027
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- May 6, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary objective of Part A of this study is to investigate the safety and tolerability of AMG 732 after single subcutaneous (SC) doses. The primary objective of Part B of this study is to investigate the efficacy of AMG 732 in participants with Thyroid Eye Disease (TED) after multiple SC doses.
Conditions
- Thyroid Eye Disease
Interventions
AMG 732Drug
SC injection
PlaceboOther
SC injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A: Number of Participants With Treatment-emergent Adverse EventsTime frame: Day 1 through Week 36 (End of Study)
- Part B: Change from Baseline in Proptosis Measurement by an Exophthalmometer in the Study EyeTime frame: Baseline to End of Treatment (EoT) (approximately 6 Months)
Locations
44 sites in 12 countries. Site status is shown where the registry gives one.
Applied Research Center of Arkansas
Little Rock, Arkansas
Amy Patel Jain MD
Newport Beach, California
Levenson Eye Associates
Jacksonville, Florida
Ilumina Medical Research
Kissimmee, Florida
Sarasota Retina Institute
Sarasota, Florida
Vision Medical Research, Inc.
Orland Park, Illinois
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts
Ppd Las Vegas Research Unit
Las Vegas, Nevada
Erie Retina Research
Erie, Pennsylvania
Baylor College of Medicine Medical Center
Houston, Texas
Consano Clinical Research, LLC
Shavano Park, Texas
West Virginia University
Morgantown, West Virginia
Macquarie University
North Ryde, New South Wales, Australia
North Shore Private Hospital
St Leonards, New South Wales, Australia
Vancouver General Hospital
Vancouver, British Columbia, Canada
Santé Québec Est-de-l'Île-de-Montréal - Universitaire
Montreal, Quebec, Canada
CHU de Québec-Université Laval - CUO-Recherche Clinique, Hopital du Saint-Sacrement
Québec, Quebec, Canada
Centre Hospitalier Universitaire de Nantes - Hopital Nord Laennec
Nantes, France
Hopital Pitie-Salpetriere
Paris, France
Universitaetsklinikum Essen
Essen, Germany
Buergerhospital und Clementine Kinderhospital gGmbH
Frankfurt am Main, Germany
Universitaetsklinikum Freiburg
Freiburg im Breisgau, Germany
Universitaetsklinikum Leipzig AoeR
Leipzig, Germany
General Hospital of Athens Laiko
Athens, Greece
Ippokratio General Hospital of Thessaloniki
Thessaloniki, Greece
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
Milan, Italy
Azienda Ospedaliero Universitaria Pisana
Pisa, Italy
Azienda Ospedaliero Universitaria Pisana
Pisa, Italy
Azienda Socio Sanitaria Territoriale dei Sette Laghi
Varese, Italy
Aichi Medical University Hospital
Nagakute-shi, Aichi-ken, Japan
Hayashi Eye Hospital
Fukuoka, Fukuoka, Japan
Kozawa Eye Hospital And Diabetes Center
Mito, Ibaraki, Japan
University of Miyazaki Hospital
Miyazaki, Miyazaki, Japan
Profesorskie Centrum Medyczne Spolka z Ograniczona Odpowiedzialnoscia
Gdansk, Poland
Uniwersyteckie Centrum Stomatologii I Medycyny Specjalistycznej Spzoo
Poznan, Poland
Dc-Med Spolka z Ograniczona Odpowiedzialnoscia Spolka Komandytowa
Swidnica, Poland
Eb Group Spolka z ograniczona odpowiedzialnoscia
Warsaw, Poland
National University Hospital
Singapore, Singapore
Singapore National Eye Centre
Singapore, Singapore
Hospital Universitario Ramon y Cajal
Madrid, Spain
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.